Glaucoma is the leading cause of irreversible blindness worldwide, and the burden of the
disease continues to grow as the global population ages. Currently, the only treatment …

Glaucoma is the main cause of irreversible visual loss worldwide, and comprises a group of
progressive, age-related, and chronic optic neuropathies. Prostaglandin analogs are …

Glaucoma is a common neurodegenerative disease characterized by progressive retinal
ganglion cell (RGC) loss and visual field defects. Pathologically high intraocular pressure …

Objectives: Identify the risk factors for open-angle glaucoma. Explain how to diagnose open-
angle glaucoma. Summarize the treatment options available for patients with open-angle …

Objective Glaucoma has currently become the second leading cause of blindness in the
world. Serum vitamin B12 level has been found to be involved in the development and …

Featured Application This study was the first to use drop-coating deposition Raman
spectroscopy (DCDRS) for the tear-based detection of glaucoma, including primary open …

Modeling complex eye diseases like age-related macular degeneration (AMD) and
glaucoma poses significant challenges, since these conditions depend highly on age …

The 18 kDa translocator protein (TSPO) is an essential outer mitochondrial membrane
protein that is responsible for mitochondrial transport, maintenance of mitochondrial …

Brinzolamide (BRZ) is a highly selective carbonic anhydrase (CA) inhibitor which leads to
decreases intraocular pressure (IOP) by slowing down the production of aqueous humour. It …

Polymorphisms rs2472493 near ABCA1, rs7636836 in FNDC3B, and rs61275591 near the
ANKRD55–MAP3K1 genes were previously reported to exhibit genome-wide significance in …